Factors influencing the use of topical steroid based medications in tinea infection in a tertiary care centre, Tamilnadu

Dhanalakshmi Kathirvel, A Sudarvizhi, Gladius Jennifer


Background  Steroid modified tinea has become the worst nightmare to the society which delays the access to the proper treatment and sometimes leaves  permanent mark on the user. This is because of the unawareness of the molecules in the medications used, both by the user and the prescriber.


Objectivem  To elucidate the common social factors involved in the misuse of topical steroids in fungal infections.


Methods  Over a period of 6 months, 187 patients were enrolled in the study with informed consent. Their demographic profile, socioeconomic status (SES), educational level, clinical picture, adverse events were noted in this study.


Results  Equal sexual distribution was noted and 21-30 year age group is the commonest age in this study (37.5%). High school graders (49%) and undergraduate holders (26%) were using the irrelevant fixed dose combinations (FDCs) and also the class 3&4 (42.%&32%) of SES.  Irrelevant FDCs (86.6%) were misused more than plain steroids. Pseudo imbricata pattern (27%), classical annular (25%) and psoriasiform patterns (21%) were common. Tinea cruris (40%) and tinea corporis (33%) were the common findings. KOH was positive in 91%.


Conclusion Limiting the production of the Irrelevant FDCs by stringent measures and including topical medication in medical undergraduate curriculum and health education to the community are all needed to combat this menace.



Irrelevant FDC; tinea; socio economic status (SES); OTC steroid; dermatophytosis

Full Text:



Panda S, Verma S. The menace of dermatophytosis in India: The evidence that we need. Indian J Dermatol Venereol Leprol 2017;83:281-4.

Mohan Bairwa, Meena Rajput, Sandeep Sachdeva. Modified Kuppusamy’s Socioeconomic scale: Social researcher should include updated income criteria, 2012. Indian J Community Med. 2013;38(3): 185-6.

Verma SB. Topical corticosteroid misuse in India is harmful and out of control. BMJ 2015;351: h6079.

Dabas R, Janney MS, Subramaniyan R, Arora S, Lal VS, Donaparthi N. Use of over-the-counter topical medications in dermatophytosis: A cross-sectional, single-center, pilot study from a tertiary care hospital. Indian J Drugs Dermatol. 2018;4:13-7.

Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: An appraisal. Indian J Dermatol. 2017;62:227-36.

Dutta B, Rasul ES, Boro B. Clinico-epidemiological study of tinea incognito with microbiological correlation. Indian J Dermatol Venereol Leprol 2017;83:326-31.

Som jithendra Lakhani, Freny Bilimoria, jithendra D Lakhani. Adverse effects of steroid use in dermatophytic infections: a cross sectional study. JIHS. 2017;5(2): 63-6.

Akram ansar, Mahmoud farschian etc. Clinico Epidemiological and Mycological aspects of Tinea incognito in Iran: A 16 year study. Med Mycol J. 2011;52: 25-32.

Kim W-J, et al. Tinea Incognito in Korea and Its Risk Factors: Nine year multicentre survey. Korean Med Sci 2013; 28: 145-51.

Gerceker Turk et al. Clinical and Mycological Analysis of Twenty-One Cases of Tinea Incognita in the Aegean Region of Turkey: A Retrospective Study. Acta Dermatovenerol Croat. 2013;21(2):93-8.

C. Romana,E. Maritati, C.Giani. Tinea incognito in Italy: a 15 year survey. Mycoses 2006;49(5): 383-7.

Vineetha M, Sheeja S, Celine MI, Sadeep MS, Palackal S, Shanimole PE, et al. Profile of dermatophytosis in a tertiary care center. Indian J Dermatol. 2018;63:490-5.

Coondoo A. Topical corticosteroid misuse: The Indian Scenario. Indian J Dermatol 2014;59:451-5.


  • There are currently no refbacks.

ISSN: 1560-9014